Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Mexico plays down Sputnik vaccine delays after domestic production deal

FILE PHOTO: A syringe with a dose of the Sputnik V coronavirus disease (COVID-19) vaccine is pictured in Xochimilco on the outskirts of Mexico City, Mexico March 3, 2021. REUTERS/Edgard Garrido

Mexican Foreign Minister Marcelo Ebrard on Wednesday played down delays in shipments of Russia's Sputnik V vaccine during a trip to Moscow where he worked out a deal to produce the shot domestically to speed up its rollout.

Mexico has relied heavily on foreign vaccines, including Sputnik, to supplement its slow vaccination campaign, but delays have hampered efforts to cover its population of 126 million.

"Virtually all companies have had delays," Ebrard said in audio comments shared by his ministry. "There's not a single one that has 100% met its delivery schedules for different reasons."

Russia has shipped just over a million Sputnik V doses to Mexico to date, far fewer than the number originally slated. Mexico said in February it planned to receive 7.4 million doses of Sputnik V by April and 16.6 million more shots in May.

Mexico has signed an agreement to acquire 24 million doses.

Ebrard said Mexico was one of the countries that had thus far received the most Sputnik vaccines.

Earlier, he announced that Mexico's state-run vaccine manufacturer Birmex would handle the final packaging and filling of the vaccine.

Bottling the Russian shot in Mexico could start as early as May, the Russian Direct Investment Fund (RDIF), which markets the vaccine abroad, said on Twitter.

About a million people in Mexico had been vaccinated with Sputnik V thus far, Ebrard said.

"The results are very positive, which speaks of the quality of science and technological development in (Russia)," he said.

Ebrard said the vaccine's active ingredient would be sent to Mexico from Russia, though that could change in due course.

"If we had the packaging capacity in Mexico as we're doing now with (Chinese vaccine) CanSino or AstraZeneca, the possibilities of having a greater number of doses would increase," he added.

(Reporting by Polina Ivanova in Moscow; additional reporting by Cassandra Garrison, Raul Cortes and Sharay Angulo in Mexico City; Editing by Bernadette Baum and Mark Heinrich)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.